Pearls from 06/21/2022 LEADS

The June 21, 2022, session of Duke Medicine LEADS featured  Teresa Tarrant, MD presenting on "Cytokine Signaling and Biologics in Atopic Disease." 


  1. Targeted T helper 2 (Th2) biologic therapy is safe and effective for patients with atopic disease. 
  2. In atopic patients where antihistamines and topical corticosteroids have failed and where allergen immunotherapy may not be feasible, therapeutic targeting of cytokine signaling pathways may provide substantial improvement in quality of life outcomes.

Watch the recorded session

Duke Medicine Learning, Education, and Discussion Series (LEADS) takes place each Tuesday at 12 p.m. Learn more and see schedule of upcoming sessions.